I.V.F. patients are faced with a growing list of costly “add-ons.” For one such test, some say more robust research is needed to support its effectiveness.
from NYT > Health https://ift.tt/3soQzii
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment